Riskpilot← Back to searchSign inGet full accessMalary AB
ABActiveOrg 5567511844Ljungsäterstigen 8Other activities auxiliary to financial services, except insurance and pension funding · NACE 6619Est. 20080 employees
Revenue 2025
SEK 3,9M
+95% vs 2024
EBITDA margin
53.6%
+125% vs 2024
Equity ratio
47.5%
Financial strength
Net profit 2025
SEK 538K
-35% vs 2024
| Revenue | SEK 3,9M | +95% |
| EBITDA | SEK 2,1M | +125% |
| Net profit | SEK 538K | -35% |
| Total assets | SEK 4M | +42% |
| Equity | SEK 1,9M | +21% |
| Employees | 0 | — |
Legal name
Malary AB
Org number
5567511844
Legal form
Aktiebolag
NACE code
6619 · Other activities auxiliary to financial services, except insurance and pension funding
Founded
1 februari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Rylander, Lars Magnus
Company purpose
Bolaget ska bedriva förvaltning av fast och lös egendom, konsultverksamhet inom finansiell rådgivning, värdepappershandel samt idka därmed förenlig verksamhet. Utöver ovan nämnda verksamheter kommer bolaget även utföra konsulttjänster inom trädgårdsdesign, rådgivning avseende växtkomposition och trädgårdsskötsel samt annan därmed förenlig verksamhet. Därtill ska Bolaget bedriva handel av växter, redskap och andra därmed besläktade produkter.
Address
Ljungsäterstigen 8
Phone
+46851783780
Email
rylander.magnus@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 2 328 | 2 382 | 1 549 | 1 999 | 3 901 |
| Staff expenses | — | — | — | — | — | — | — | — | −806 | −1 314 |
| EBITDA | 6 | −11 | −11 | 3 | −3 | 1 324 | 1 087 | 497 | 930 | 2 091 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — |
| EBIT | 6 | −11 | −11 | 3 | −3 | 1 324 | 1 087 | 497 | 930 | 2 091 |
| Net financials | 1 | −1 | −316 | — | — | — | — | −900 | 285 | −697 |
| Profit before tax | 445 | 163 | −273 | 222 | −3 | 993 | 814 | 48 | 975 | 864 |
| Tax | −99 | −36 | −10 | −49 | −0 | −213 | −168 | −105 | −148 | −327 |
| Net profit | 346 | 127 | −283 | 173 | −3 | 780 | 646 | −57 | 827 | 538 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 538 | 1 173 | 566 | 357 | 174 | 1 590 | 2 356 | 2 035 | 2 826 | 4 021 |
| Equity | 773 | 740 | 294 | 298 | 124 | 903 | 1 189 | 944 | 1 575 | 1 909 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 316 | 160 | 52 | 59 | 50 | 355 | 563 | 487 | 407 | 740 |
| Total debt | 316 | 160 | 52 | 59 | 50 | 355 | 563 | 487 | 407 | 740 |
EBITDA margin
53.6%
This company
15.8%
Market median
+239% vs market
20162025
Equity ratio
47.5%
This company
38.2%
Market median
+24% vs market
20162025
Return on equity
28.2%
This company
18.4%
Market median
+53% vs market
20162025
Net profit margin
13.8%
This company
8.1%
Market median
+70% vs market
20162025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20162025
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Malary AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ingrid Elisabet Rylander | Board of Directors | 0 companies |
| Karl Jonas Rylander | Deputy Board Member | 0 companies |
| Lars Magnus Rylander | Chairman | 0 companies |